VisionPoint Advisory Group’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8K Buy
11,712
+96
+0.8% +$300 0.01% 473
2026
Q1
$33.9K Sell
11,616
-2,838
-20% -$8.11K 0.01% 438
2025
Q4
$35.7K Buy
+14,454
New +$34.4K 0.01% 393
2023
Q4
Sell
-245,932
Closed -$635K 747
2023
Q3
$635K Sell
245,932
-177,257
-42% -$513K 0.27% 82
2023
Q2
$1.35M Buy
423,189
+174,459
+70% +$513K 0.55% 53
2023
Q1
$724K Buy
248,730
+149,158
+150% +$390K 0.32% 66
2022
Q4
$250K Buy
+99,572
New +$290K 0.1% 120

Other funds holding ABEV

VisionPoint Advisory Group's ABEV Position: Q2 2026 in Review

VisionPoint Advisory Group increased its Ambev (ABEV) stake by 0.83% in Q2 2026, buying an estimated $300 and bringing the position to 11,712 shares worth $36.8K. The position accounts for 0.01% of the portfolio, ranked #473.

VisionPoint Advisory Group first reported a position in ABEV in Q4 2022 and has held it in 7 quarters since. The position peaked at $1.35M in Q2 2023. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • VisionPoint Advisory Group held 11,712 shares of Ambev worth $36.8K as of Q2 2026.
  • VisionPoint Advisory Group bought 96 Ambev shares in Q2 2026, an estimated $300.
  • Ambev made up 0.01% of VisionPoint Advisory Group's portfolio in Q2 2026, its #473 holding.
  • VisionPoint Advisory Group first reported a position in Ambev in Q4 2022 and has held it in 7 quarters since.
  • VisionPoint Advisory Group's Ambev position peaked at $1.35M in Q2 2023.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.